OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model

被引:0
|
作者
Song, Xiaomeng [1 ]
Liu, Tengfei [1 ]
Yu, Lu [1 ]
Ji, Qiuran [1 ]
Guo, Xin [1 ]
Zong, Runzhe [1 ]
Li, Yiquan [1 ]
Huang, Gan [1 ]
Xue, Qidi [1 ]
Fu, Qingyi [1 ]
Liu, Bingyu [2 ,3 ]
Zheng, Yi [2 ,3 ]
Chen, Lin [1 ]
Gao, Chengjiang [2 ,3 ]
Liu, Huiqing [1 ,4 ]
机构
[1] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, Jinan 250012, Shandong, Peoples R China
[3] Shandong Univ, Sch Basic Med Sci, Dept Immunol, Jinan 250012, Shandong, Peoples R China
[4] Shandong Univ, Hosp 2, Dept Rehabil Med, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
deubiquitinase; endolysosomal pathway; nedd4; otud5; parkinson's disease; alpha-synuclein; DEUBIQUITINASE; AUTOPHAGY; PATHWAYS; PROTEINS; SYSTEMS; BRAIN; DUBA;
D O I
10.1002/advs.202406700
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Defective clearance and accumulation of alpha-synuclein (alpha-Syn) is the key pathogenic factor in Parkinson's disease (PD). Recent studies emphasize the importance of E3 ligases in regulating the degradation of alpha-Syn. However, the molecular mechanisms by which deubiquitinases regulate alpha-Syn degradation are scarcely studied. In this study, it is found that the protein levels of alpha-Syn are negatively regulated by ovarian tumor protease deubiquitinase 5 (OTUD5) which protects dopaminergic (DA) neurons in the PD model. Mechanistically, OTUD5 promotes K63-linked polyubiquitination of alpha-Syn independent of its deubiquitinating enzyme activity and mediates its endolysosomal degradation by recruiting the E3 ligase neural precursor cell expressed developmentally downregulated 4 (NEDD4). Furthermore, OTUD5 conditional knockout in DA neurons results in more severe alpha-Syn related pathology and dyskinesia after injection of alpha-Syn preformed fibrils (PFF). Overall, the data unveil a novel mechanism to regulate the degradation of alpha-Syn and provide a new therapeutic strategy to alleviate DA neurodegeneration.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
    Alexander Grotemeyer
    Judith F. Fischer
    James B. Koprich
    Jonathan M. Brotchie
    Robert Blum
    Jens Volkmann
    Chi Wang Ip
    Journal of Neuroinflammation, 20
  • [2] Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease
    Grotemeyer, Alexander
    Fischer, Judith F.
    Koprich, James B.
    Brotchie, Jonathan M.
    Blum, Robert
    Volkmann, Jens
    Ip, Chi Wang
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [3] Colchicine Protects Dopaminergic Neurons in a Rat Model of Parkinson's Disease
    Salama, Mohamed
    Ellaithy, Amr
    Helmy, Basem
    El-Gamal, Mohamed
    Tantawy, Dina
    Mohamed, Mie
    Sheashaa, Hussein
    Sobh, Mohamed
    Arias-Carrion, Oscar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (07) : 836 - 843
  • [4] Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson's disease
    Wen Jing
    Zhang Yuan-Qiang
    Liu Dong-Qing
    Yao Xu-Tao
    Jiang Hua
    Zhang Yu-Bin
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (02) : 111 - 119
  • [5] BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease
    Vitic, Zagorka
    Safory, Hazem
    Jovanovic, Vukasin M.
    Sarusi, Yael
    Stavsky, Alexandra
    Kahn, Joy
    Kuzmina, Alona
    Toker, Lilah
    Gitler, Daniel
    Taube, Ran
    Friedel, Roland H.
    Engelender, Simone
    Brodski, Claude
    BRAIN, 2021, 144 (02)
  • [6] Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease
    Jesus Amo-Aparicio
    Jonathan Daly
    Jesper Falkesgaard Højen
    Charles A. Dinarello
    Journal of Neuroinflammation, 20
  • [7] Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
    Benner, EJ
    Mosley, RL
    Destache, CJ
    Lewis, TB
    Jackson-Lewis, V
    Gorantla, S
    Nemachek, C
    Green, SR
    Przedborski, S
    Gendelman, HE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) : 9435 - 9440
  • [8] Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model
    Sawada, H
    Ibi, M
    Kihara, T
    Honda, K
    Nakamizo, T
    Kanki, R
    Nakanishi, M
    Sakka, N
    Akaike, A
    Shimohama, S
    NEUROPHARMACOLOGY, 2002, 42 (08) : 1056 - 1064
  • [9] Pharmacologic inhibition of NLRP3 reduces the levels of a-synuclein and protects dopaminergic neurons in a model of Parkinson's disease
    Amo-Aparicio, Jesus
    Daly, Jonathan
    Hojen, Jesper Falkesgaard
    Dinarello, Charles A.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [10] PUERARIN PROTECTS DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE MODELS
    Zhang, X.
    Xiong, J.
    Liu, S.
    Wang, L.
    Huang, J.
    Liu, L.
    Yang, J.
    Zhang, G.
    Guo, K.
    Zhang, Z.
    Wu, P.
    Wang, D.
    Lin, Z.
    Xiong, N.
    Wang, T.
    NEUROSCIENCE, 2014, 280 : 88 - 98